Two distinct phenotypes caused by two different missense mutations in the same codon of the VHL gene
- 25 October 1999
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics
- Vol. 87 (2) , 163-167
- https://doi.org/10.1002/(sici)1096-8628(19991119)87:2<163::aid-ajmg7>3.0.co;2-a
Abstract
We have identified a family segregating von Hippel-Lindau (VHL) disease with a previously unreported T547A mutation in exon 1 of the VHL gene that causes a Tyr112 to Asn missense alteration in the protein. The mutation was identified by nucleotide sequencing and confirmed by restriction enzyme digestion. The mutation cosegregated with the disease in all five tested affected individuals from the extended family. The family consists of more than 100 at-risk individuals over seven generations. To date, we have identified 13 affected individuals of whom seven have had renal cell carcinoma and one has had a pheochromocytoma. No other case of a neuroendocrine tumor of the pancreas or adrenal gland (pheochromocytoma) was found or recognized retrospectively. Other manifestations in this family include retinal angioma and hemangioblastoma of the central nervous system. We also found the T547A mutation in three asymptomatic members of the family, ages 12, 19, and 20. Another mutation, T547C, which causes Tyr112 to His, has been seen at the same position and has been associated with VHL type 2A (pheochromocytoma, but no renal cell carcinoma) in two families with a total of 22 affected individuals [Chen F, Slife L, Kishida T, Mulvihill J, Tisherman SE, Zbar B, 1996: J Med Genet 33:716–717]. Thus, different amino acid changes at the same position can cause very distinct clinical phenotypes. It will be interesting to elucidate the functional differences that underlie the different phenotypes. Am. J. Med. Genet. 87:163–167, 1999.Keywords
This publication has 23 references indexed in Scilit:
- Different mutations in the same codon of the proteolipid protein gene,PLP, may help in correlating genotype with phenotype in Pelizaeus-Merzbacher disease/X-linked spastic paraplegia (PMD/SPG2)American Journal of Medical Genetics, 1999
- pVHL 19 is a biologically active product of the von Hippel–Lindau gene arising from internal translation initiationProceedings of the National Academy of Sciences, 1998
- The importance of heteroduplexes in interpreting the results of PCR-RED diagnostic assays: Application to the analysis of mutations in the steroid 21-hydroxylase gene in a case of congenital adrenal hyperplasiaMolecular Diagnosis, 1998
- Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.Proceedings of the National Academy of Sciences, 1996
- Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene.Proceedings of the National Academy of Sciences, 1996
- Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2A.Journal of Medical Genetics, 1996
- Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central EuropeHuman Genetics, 1996
- Inhibition of Transcription Elongation by the VHL Tumor Suppressor ProteinScience, 1995
- Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotypeHuman Mutation, 1995
- Mutations of the VHL tumour suppressor gene in renal carcinomaNature Genetics, 1994